When a TMS insurance denial appeal letter arrives, it can feel like a dead end. In our experience, most denials are reversible once you understand the specific reason behind them and put together the right documentation. Before you start, gather your denial letter, your medication trial history, and your diagnosis records. This guide focuses only on the appeals and paperwork process, not on how TMS works as a treatment, so if you want background on the therapy itself or what it costs, our pages on TMS therapy costs and TMS success rates cover that ground well.
Every denial letter is required to include a specific reason, usually tied to a denial code and a plain-language explanation. Do not skim this section. Insurance companies are obligated to tell you why they rejected the TMS prior authorization request, and that reason determines everything about your appeal strategy going forward. If the letter is vague or the language feels like boilerplate, call the number on the letter and ask the representative to read you the exact clinical criteria that were not met.
Denials generally fall into a handful of categories. The most common is insufficient documentation of failed medication trials, meaning the payer does not believe you tried enough antidepressants at adequate doses for long enough before requesting TMS. Others involve diagnosis coding problems, where the billed diagnosis does not match what the plan’s TMS policy covers. Some denials point to missing clinical notes, such as a lack of recent psychiatric evaluation or standardized symptom scores. And occasionally a denial simply states that medical necessity was not established, which is often a sign that the clinical notes submitted did not use the language the payer’s review criteria expect to see.
Once you know the category, look for the appeal deadline. Most plans give you somewhere between 60 and 180 days to file an internal appeal, but this window varies by plan and by state, so check your plan documents rather than assume. Missing this deadline can forfeit your right to appeal internally, which then complicates any later request for external review. Mark the deadline immediately and build your timeline backward from it, since gathering records from multiple providers can take longer than expected.
Knowing the mechanics behind a denial helps you respond to it precisely instead of generally. As of 2026, most payers require documented failure of several antidepressant trials, often four or more, each at an adequate dose and for an adequate duration, before they will approve TMS. The exact number and definition of “adequate” varies by insurer and even by plan year, so do not assume your plan’s rule matches a number you read elsewhere. Confirm the specific requirement listed in your denial letter or in the plan’s medical policy document for TMS.
Diagnosis coding errors are another frequent and, importantly, fixable cause of denial. If your chart lists a diagnosis code that is not covered under the plan’s TMS medical policy, even a well-documented case can get rejected on a technicality. This sometimes happens when a patient carries multiple diagnoses and the wrong one gets listed as primary on the prior authorization request. A quick correction and resubmission can resolve this type of denial faster than a full appeal.
Finally, documentation gaps trip up plenty of patients who clinically qualify for TMS but whose paperwork does not show it. Missing PHQ-9 or GAD-7 scores, which are standardized questionnaires that measure depression and anxiety severity, are a common gap. So are missing therapy notes or a psychiatric evaluation that is too old to reflect current symptom severity. Payers want to see a clear, continuous record of impairment and treatment attempts, not just a summary statement from your doctor.
This step is the foundation of a strong appeal, and it usually takes the most time. Start by requesting full medication records from every prescriber you have seen for depression, not just your current psychiatrist. For each medication, you want the drug name, the dose, how long you took it, and the documented reason it was discontinued, whether that was lack of response, intolerable side effects, or another factor. Insurers weigh this history heavily, and incomplete records are one of the most avoidable reasons an appeal fails.
Alongside medication records, collect any therapy notes, psychiatric evaluation summaries, and standardized symptom scores like PHQ-9 or GAD-7 results that show ongoing impairment over time. A single low score from years ago will not carry much weight. What helps is a pattern, several scores over months or years that show the depression has persisted despite treatment attempts.
Once you have gathered the raw records, ask your treating psychiatrist to write a brief clinical summary letter. This letter should not simply restate your history. It should connect that history directly to the payer’s stated criteria for TMS coverage. For example, if the denial letter says you need documentation of four failed medication trials at adequate dose and duration, the summary should state plainly: “Patient has failed adequate trials of [medication], [medication], [medication], and [medication], each at therapeutic dose for at least six weeks, as documented in the attached records.” This kind of direct mapping between your history and the payer’s own language is often the difference between a second denial and an approval.
Your insurance appeal letter for TMS should be organized so a reviewer can verify your case quickly, since medical directors and appeal reviewers often handle a high volume of files and do not have time to hunt for information. Start with patient identifiers, including your name, date of birth, member ID, and the denial reference number from your original letter. State your diagnosis clearly, along with the specific diagnosis code your provider is using, and follow with a direct statement of medical necessity that explains why TMS is the appropriate next step in your care.
The body of the letter should address the exact denial reason from Step 1, point by point. If the payer cited insufficient medication trials, list each trial with dose, duration, and outcome, referencing the attached records. If the denial cited a diagnosis coding issue, explain the correction and cite the updated code. Avoid restating your entire medical history in narrative form. Reviewers respond better to a letter that mirrors the structure of their own denial reasoning, since it shows you understood their objection and answered it directly rather than submitting a generic appeal.
Attach your supporting documents as labeled exhibits: Exhibit A for the medication trial list, Exhibit B for symptom scores, Exhibit C for your physician’s clinical summary, and so on. Reference each exhibit by letter within the body of the letter so the reviewer can cross-check your claims without searching through a stack of loose paperwork. Keep a complete copy of everything you send, including the mailing or fax confirmation, since you may need this record again if the appeal moves to a second level or to external review.
Many appeals include an option for a peer to peer review, which is a phone conversation between your treating physician and the insurance company’s medical director. This is a conversation between clinicians, not something the patient participates in directly, and that distinction matters. A medical director wants to discuss clinical reasoning with another physician, and having the patient attempt this call instead of the treating doctor is one of the more common and avoidable mistakes we see.
Before the call, your physician should prepare a short clinical narrative, essentially a condensed version of the appeal letter, that can be delivered verbally in a few minutes. It helps enormously if your doctor has the specific medication trials and the payer’s own diagnosis criteria on hand during the call, since medical directors will often ask pointed questions about dose, duration, and diagnostic specifics. A doctor who can answer precisely and quickly tends to move the conversation toward approval faster than one who has to look up details mid-call.
Ask your clinic’s billing or authorization coordinator to schedule this call as soon as it becomes available, since delays here can add weeks to an already lengthy appeal timeline. Some payers have a limited scheduling window for peer to peer reviews, and missing it can push your case into a longer written appeal process instead. If your treating physician’s schedule is tight, ask the coordinator whether a nurse practitioner or physician assistant familiar with your case can join as backup, though the physician of record should still be the one speaking with the medical director whenever possible.
If your first appeal is rejected, most plans offer a second level of internal appeal before you can pursue external review. Start by requesting, in writing, the specific clinical criteria the payer used to deny your case. In most states, insurers are required to disclose this information, and having it in writing gives you something concrete to respond to rather than guessing at what changed between the first and second review.
Resist the temptation to simply resend the same appeal packet. A second level appeal needs something new: an updated symptom score, a specialist consultation letter, additional medication trial documentation, or a more detailed physician narrative that addresses whatever gap the first reviewer identified. Payers are unlikely to reverse a decision based on paperwork they have already reviewed once, so treat this step as an opportunity to close whatever hole remains in your case.
Pay close attention to deadlines here, since second level appeal windows are often shorter than the first, sometimes as brief as 30 days from the first denial. State insurance regulations add another layer of variation, so it is worth a quick call to your state’s department of insurance or a review of your plan’s appeal procedures document to confirm the exact deadline that applies to you.
If both internal appeals are denied, you generally have the right to request an external independent review, a process established under the Affordable Care Act’s internal and external review framework and administered either through your state insurance department or a federal process, depending on your plan type and state. This step matters because independent medical reviewers are not employed by your insurance company, and their decision is typically binding on the plan. That independence is exactly why this stage often produces different outcomes than the internal appeals did.
To request external review, you will usually need to file within a set window after your final internal denial, often four months, though this varies by state, so confirm the current rule with your state insurance department rather than relying on a general timeline. The reviewing organization will ask for your complete appeal file, including the original denial letter, both internal appeal letters, all supporting medical documentation, and any correspondence from the peer to peer review.
This is why we recommend keeping copies of every document you have submitted throughout the entire process, from Step 1 forward. External reviewers frequently request the full history rather than just the most recent appeal, and missing pieces can slow down a review that is otherwise your best remaining chance at approval. If the external review favors you, the insurer is generally required to authorize the treatment, which means this stage, while it can feel like the end of a long road, often resolves in the patient’s favor when the clinical case has been well documented from the start.
An appeal that follows this sequence, reading the denial closely, understanding the payer’s reasoning, gathering thorough records, writing a targeted letter, preparing your physician for peer to peer review, and escalating methodically when needed, gives you the strongest possible chance at getting TMS approved. If you are stuck at any stage of a TMS insurance denial appeal, our team at Delray Brain Science can review your denial letter and help you build the documentation your appeal needs. You can also learn more about our approach to care on our homepage. Learn more about our services and reach out to us today to talk about your coverage and next steps.
